SEC Form SC 13D/A filed by My Size, Inc. (Amendment)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

§ 240.13d-2(a)

(Amendment No. 3)¹

My Size, Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

62844N208

(CUSIP Number)

David E. Lazar

c/o ACTIVIST INVESTING llc

1185 Avenue of the Americas, Third Floor

New York, New York 10036

(646) 768-8417

SPENCER FELDMAN, ESQ.

Kenneth A. Schlesinger, ESQ.

OLSHAN FROME WOLOSKY LLP

1325 Avenue of the Americas

New York, New York 10019

(212) 451-2300

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

November 4, 2021

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this Schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

The following constitutes Amendment No. 3 to the Schedule 13D filed by the undersigned (“Amendment No. 3”). This Amendment No. 3 amends the Schedule 13D as specifically set forth herein. This Amendment No. 3 is being refiled to include signatures of the Reporting Persons that were previously omitted on this Amendment No. 3 and the Joint Filing Agreement defined and described in Item 6 below when originally filed.

Item 2 is hereby amended to add the following:

In connection with the Settlement Agreement defined and described in Item 4 below, David Aboudi, Patrick Loney and David Natan (collectively, the “Director Nominees”) are no longer members of the Section 13(d) group and shall cease to be Reporting Persons immediately after the filing of this Amendment No. 3. The remaining Reporting Persons will continue filing as a group statements on Schedule 13D with respect to their beneficial ownership of securities of the Issuer to the extent required by applicable law. Each of the remaining Reporting Persons is party to the Joint Filing Agreement defined and described in Item 6 below.

Item 4 is hereby amended to add the following:

On November 4, 2021, Custodian Ventures LLC and certain of its affiliates (collectively, “Custodian”) and the Director Nominees entered into an agreement (the “Settlement Agreement”) with the Issuer.

Pursuant to the Settlement Agreement, Custodian, the Director Nominees and the Issuer agreed to compromise and settle the following claims asserted against one another: (i) the action commenced by Custodian pursuant to Section 211 of the Delaware General Corporation Law against the Issuer in the Court of Chancery of the State of Delaware, captioned Custodian Ventures LLC v. My Size, Inc., C.A. No. 2021-0817-LWW, and (ii) the civil action filed by the Issuer in the United States District Court of the Southern District of New York, My Size, Inc. v. Lazar et al., No. 1:21-cv-08585.

In addition, pursuant to the Settlement Agreement, the Issuer agreed to reimburse Custodian for out of pocket expenses and in consideration for the dismissal and release of claims against the Issuer an aggregate amount equal to $275,000, to be paid within three business days of the effective date of the Settlement Agreement.

With respect to the Issuer’s 2021 annual meeting of stockholders (the “2021 Annual Meeting”), Custodian agreed to, among other things, withdraw or rescind (i) its May 12, 2021 notice of stockholder nominations of four director candidates with respect to the 2021 Annual Meeting, (ii) the notice dated October 28, 2021 submitted by Custodian to the Issuer notifying the Issuer of Custodian’s continued intent to bring its nomination of four director candidates before the Issuer’s stockholders at the 2021 Annual Meeting, and (iii) any and all related materials and notices submitted to the Issuer in connection therewith or related thereto and to not take any further action in connection with the solicitation of any proxies in connection with the Issuer. Custodian also agreed to cease any and all solicitation and other activities in connection with the 2021 Annual Meeting.

In addition, Custodian and the Director Nominees agreed to certain customary standstill provisions for a period of five years beginning on the effective date of the Settlement Agreement (the “Standstill Period”). The Settlement Agreement also provides that during the Standstill Period, Custodian and the Director Nominees will vote all Shares of the Issuer beneficially owned in in accordance with any proposal or recommendation made by the Issuer or the Board of Directors of the Issuer that is submitted to the stockholders of the Issuer, except with respect to certain extraordinary transactions and unless to do so would violate applicable law.

The Settlement Agreement also contains non-disparagement and confidentiality provisions, subject to certain exceptions.

The foregoing description of the Settlement Agreement is qualified in its entirety by reference to the full text of the Settlement Agreement, a copy of which is filed as Exhibit 10.1 in the Issuer’s Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on November 5, 2021, and is incorporated herein by reference.

Items 5(a) – (c) are hereby amended and restated to read as follows:

The aggregate percentage of Shares reported owned by each person named herein is based upon 20,210,295 Shares outstanding, as of October 28, 2021, which is the total number of Shares outstanding as reported in the Issuer’s Prospectus on Form 424B5 filed with the SEC on October 28, 2021.

Percentage: Approximately 2.1%

Percentage: Approximately 3.4%

Percentage: Approximately 7.4%

Percentage: 0%

Item 6 is hereby amended to add the following:

On November 4, 2021, the Reporting Persons entered into the Settlement Agreement with the Issuer as defined and described in Item 4, a copy of which is attached as Exhibit 10.1 to the Issuer’s Current Report on Form 8-K filed with the SEC on November 5, 2021 and is incorporated herein by reference.

On November 8, 2021, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons who will remain Reporting Persons subsequent to this Amendment No. 3 agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer to the extent as required by applicable law. A copy of this agreement is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

Item 7 is hereby amended to add the following exhibits:

SIGNATURES

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: November 8, 2021